作者: James A. Purdy , Philip M. Poortmans
DOI: 10.1007/174_2011_324
关键词: Multidisciplinary approach 、 Harmonization 、 Medical physics 、 Emerging technologies 、 Biomedical engineering 、 Clinical trial 、 Quality assurance 、 Evidence-based practice 、 Credentialing 、 Quality (business) 、 Medicine
摘要: The need for specific quality assurance (QA) activities in the framework of clinical trials is continually increasing as technical requirements needed optimal radiation oncology continue to evolve and become more demanding new technologies be developed implemented at a progressively higher rate. exchange digital data allowing evaluation volume delineation dose-volume parameters enabling linking these QA outcome has led development dedicated platforms software QA. All developments present credentialing challenges cooperative groups trial centers. level appropriate highly dependent on complexity trial. It should evidence based; by doing this, efficient will improve overall treatment most patients an acceptable cost. also apparent that are becoming much multicenter, multidisciplinary international, thereby not only giving additional relevance already stringent demands but putting forward critically important issue harmonization procedures. This chapter address all issues focusing primarily United States European experience.